ZBH
Zimmer Biomet Holdings Inc (ZBH)
Healthcare • NYSE • $82.33-1.25%
- Symbol
- ZBH
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $82.33
- Daily Change
- -1.25%
- Market Cap
- $15.93B
- Trailing P/E
- 21.33
- Forward P/E
- 9.16
- 52W High
- $108.29
- 52W Low
- $79.83
- Analyst Target
- $98.52
- Dividend Yield
- +1.17%
- Beta
- 0.47
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of i…
Company websiteResearch ZBH on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.